Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer.
Loening SA, Beckley S, Brady MF, Chu TM, deKernion JB, Dhabuwala C, Gaeta JF, Gibbons RP, McKiel CF, McLeod DG, Pontes JE, Prout GR, Scardino PT, Schlegel JU, Schmidt JD, Scott WW, Slack NH, Soloway MS, Murphy GP.
Loening SA, et al. Among authors: scardino pt.
J Urol. 1983 May;129(5):1001-6. doi: 10.1016/s0022-5347(17)52509-4.
J Urol. 1983.
PMID: 6343629
Clinical Trial.